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FAA1Fatty acid (FA) transport and activation have been extensively studied in the model yeast species Saccharomyces
cerevisiae but have rarely been examined in oleaginous yeasts, such as Yarrowia lipolytica. Because the latter
begins to be used in biodiesel production, understanding its FA transport and activationmechanisms is essential.
We found that Y. lipolytica has FA transport and activation proteins similar to those of S. cerevisiae (Faa1p, Pxa1p,
Pxa2p, Ant1p) butmechanism of FA peroxisomal transport and activation differs greatly with that of S. cerevisiae.
While the ScPxa1p/ScPxa2p heterodimer is essential for growth on long-chain FAs, ΔYlpxa1 ΔYlpxa2 is not
impaired for growth on FAs. Meanwhile, ScAnt1p and YlAnt1p are both essential for yeast growth on medium-
chain FAs, suggesting they function similarly. Interestingly, we found that the ΔYlpxa1 ΔYlpxa2 ΔYlant1mutant
was unable to growon short-,medium-, or long-chain FAs, suggesting that YlPxa1p, YlPxa2p, and YlAnt1p belong
to two different FA degradation pathways. We also found that YlFaa1p is involved in FA storage in lipid
bodies and that FA remobilization largely depended on YlFat1p, YlPxa1p and YlPxa2p. This study is the ﬁrst to
comprehensively examine FA intracellular transport and activation in oleaginous yeast.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Peroxisomes are very important organelles that perform different
metabolic functions, such as the β-oxidation of FAs and the synthesis
and degradation of bioactive lipid-derived molecules. Consequently,
when peroxisomes malfunction, the effects can be dramatic for cells.
Indeed, the abnormal assembly of peroxisomes is responsible for
Zellweger syndrome, rhizomelic chondrodysplasia punctata, and neo-
natal adrenoleukodystrophy in humans. In yeasts, FAs are degraded
exclusively by peroxisomes, and it has been shown that the uptake of
FAs into peroxisomes may occur via two routes. The ﬁrst route involves
the intraperoxisomal activation of free FAs into acyl-CoA esters, a pro-
cess that ismediated by ScAnt1p [38,41] and ScFaa2 [21] in Saccharomy-
ces cerevisiae. The second route involves two yeast half-ABC
peroxisomal transporters, ScPxa1p and ScPxa2p [19], and the acyl-CoA
synthetase ScFaa1 [13].
In S. cerevisiae, certain FAs are ﬁrst activated before entering the
peroxisomes. Four FA acyl-CoA synthetases, ScFaa1p to ScFaa4p, play agroParisTech, UMR1319, Team
I, F-78850 Thiverval-Grignon,
. Nicaud).
. This is an open access article underrole in FA activation [13,20,21,26]. Indeed, ScFaa1p is essential for
S. cerevisiae growth on media containing long-chain fatty acids
(LCFAs), such as palmitate [13]. In fact, ScFaa1p and, to a lesser extent,
ScFaa4p are responsible for activating exogenous FAs whereas ScFaa2p
and ScFaa3p activate only endogenous FAs [20,21]. In vitro assays
indicate that ScFaalp preferentially activates C12:0–C16:0 FAs such as
myristic acid and pentadecanoic acid and that ScFaa2p acts on C9:0–
C13:0 FAs. On the other hand, ScFaa3p is unique in that it preferentially
activates C16 and C18 FAs that contain a cis double bond at C9–C10; it is
also the only Faa protein that is able to activate C22:0 and C24:0 FAs.
When acting on C9:0–C18:0 FAs, ScFaa3p demonstrates acyl-CoA syn-
thetase activity that is 2- to 160-fold lower than that of ScFaalp and
ScFaa2p [26]. Furthermore, [60] reported that the S. cerevisiae LCFA
transporter ScFat1p may form complexes with ScFaa1p or ScFaa4p,
which suggests that exogenous FA importation and activation are
coupled in this model yeast species. Moreover, localization studies
have shown that ScFaa1p is found in the plasmamembrane, lipid parti-
cles, mitochondria, and the endoplasmic reticulum; ScFaa2p is found in
peroxisomes and the cytosol; and ScFaa4p is found in the endoplasmic
reticulum and lipid bodies [6,19,36].
Recently, [58] characterized a Faa protein, YlFaa1p (YALI0D17864p),
in the oleaginous yeast, Yarrowia lipolytica. This protein shares about
50% identity with ScFaa1p, ScFaa4p, and ScFaa3p and only 27% identitythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Strains and plasmids.
Strain or plasmid Genotype or other relevant characteristics Source or
reference
E. coli
DH5α Φ80dlacZΔm15, recA1, endA1, gyrA96,
thi-1, hsdR17 (rk−, mk+), supE44,
relA1, deoR, Δ(lacZYA-argF)U169
Promega
Y. lipolytica
W29 MATA, wild-type [2]
Po1d MATA ura3–302 leu2–270 xpr2–322 [2]
JMY330 Po1d Ura+ [18]
JMY2900 Po1d Ura + Leu+ [12]
JMY2954 Po1d ΔYlpxa1::URA3ex This study
JMY2959 Po1d ΔYlpxa2::URA3ex This study
JMY2964 Po1d ΔYlfaa1::URA3ex This study
JMY2969 Po1d ΔYlant1::URA3ex This study
JMY3159 Y2954 + ΔYlpxa2::LEU2ex This study
JMY3230 Y2954 + LEU2ex This study
JMY3233 Y2959 + LEU2ex This study
JMY3234 Y2964 + LEU2ex This study
JMY3237 Y2969 + LEU2ex This study
JMY3240 JMY3148 + LEU2ex (Ura+ Leu+) [12]
JMY3464 Y2964 + ΔYlant1::LEU2ex This study
JMY3670 Y2969 pTEF-YlANT1-LEU2ex This study
JMY3701 Y3159 Ura− Leu− This study
JMY3737 Y3701 + ΔYlant1::LEU2ex This study
JMY3795 Y3737 + URA3ex This study
JMY3797 Y2954 + ΔYlant1::LEU2ex This study
JMY3811 Y2959 + ΔYlant1::LEU2ex This study
JMY4138 Y3737 + ΔYlfat1::URA3ex This study
JMY4150 Y3701+ ΔYlfat1::URA3ex This study
JMY4160 Y4150 + LEU2ex This study
JMY4194 Y2954 + pTEF-YlPXA1-YFP-LEU2ex This study
JMY4251 Y4194 Ura− Leu− This study
JMY4253 Y2959 + pTEF-YlPXA2-YFP-LEU2ex This study
JMY4255 Y2964 + pTEF-YlFAA1-YFP-LEU2ex This study
JMY4258 Y4251 + pTEF-RedStar2-SKL-LEU2ex This study
JMY4297 Y4253 Ura + Leu− This study
JMY4327 Y4297 + pTEF-RedStar2SKL-LEU2ex This study
pCR4Blunt-TOPO Cloning vector Invitrogen
JMP547 pUB4-CRE [15]
JMP803 JMP62-pTEF-URA3ex [35,37]
JMP802 JMP62-pTEF-LEU2ex [18]
JMP1392 JMP62-pTEF-RedStar2SKL-LEU2ex [23]
JMP1394 JMP62-pTEF-RedStar2-LEU2ex T. Rossignol,
unpublished data
JMP1762 pCR4Blunt-TOPO-Ylfat1::URA3ex [12]
JMP1673 Topo YlPXA2UpDn-URA3ex This study
JMP1675 Topo YlFAA1UpDn-URA3ex This study
JMP1676 TopoYlANT1UpDn-URA3ex This study
JMP1697 Topo YlPXA1UpDn-URA3ex This study
JMP1765 Topo YlPXA2UpDn-LEU2ex This study
JMP1842 Topo YlANT1UpDn LEU2ex This study
JMP1929 Topo YlFAA1 This study
JMP1934 Topo YlANT1 This study
JMP2025 JMP62 pTEF-YlANT1-LEU2ex This study
JMP2384 JMP62 + pTEF-YlPXA1-YFP-LEU2ex This study
JMP2387 JMP62 + pTEF- YlPXA2-YFP-LEU2ex This study
JMP2390 JMP62 + pTEF- YlFAA1-YFP-LEU2ex This study
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(i) slightly reduced yeast growth on a rich medium; (ii) decreased
acyl-CoA synthetase activity; (iii) increased the ratio of saturated to
unsaturated FAs (palmitic acid/oleic acid); and (iv) increased lipid
production 1.5 fold. The authors also suggested that YlFaa1p is involved
in FA elongation and desaturation, a function that is not associatedwith
S. cerevisiae Faa enzymes.
Once FAs have been activated, they can enter the peroxisomes. In
S. cerevisiae, the heterodimer ScPxa1p/ScPxa2p is responsible for trans-
porting activated LCFAs [19,49,52]. Indeed, disruption of ScPXA1 and/or
ScPXA2 impairs yeast growth onmedia containing LCFAs as the sole car-
bon source (i.e., oleate acid and palmitate acid). Since the β-oxidation
pathway is intact in these mutants, this result suggests that ScPxa1p
and ScPxa2p are speciﬁcally involved in LCFA transport [19]. It was
recently shown that acyl-CoA esters are hydrolyzed before being trans-
ported into the peroxisomes by ScPxa1p/ScPxa2p. Moreover, ScPxa1p/
ScPxa2p transporters might be involved in some sort of functional inter-
action with ScFaa2p and/or ScFat1p on the inner surface of the peroxi-
somal membrane that results in the subsequent re-esteriﬁcation of FAs
with extremely long chains [44]. Because medium-chain fatty acids
(MCFAs) do not need ScPxa1p/ScPxa2p transporters to enter peroxi-
somes, it has been suggested that they use an alternativemechanism [19].
In S. cerevisiae, ScAnt1p is a peroxisomal transporter whose expres-
sion is induced by oleic acid and that is essential for yeast growth in
media in which MCFAs are the sole carbon source [38,41]. It mediates
ATP transport into the peroxisomes; ATP is required forMCFAs to be ac-
tivated and thus converted into their corresponding coenzyme A esters
in the peroxisomes [29,38,41,45]. Interestingly, in Y. lipolytica, YlAnt1p
has been described as being involved in short-chain alkane utilization
(mainly of C10–C11), which suggests that activation takes place in the
peroxisomes [54].
Although FA transport and activation have been extensively studied
in S. cerevisiae, few data are available for other organisms. This is partic-
ularly true for oleaginous species such as Y. lipolytica, which is able to
use hydrophobic substrates like oils, FAs, and alkanes as carbon sources
[5]. This traitmakesY. lipolytica amodel organismof great interestwhen
it comes to biotechnology applications, especially biofuel production
[4]. As a consequence, understanding FA transport and activation
mechanisms in Y. lipolyticamight help improve the species' production
of FAs (and other related processes). In this study, we therefore aimed
to explore these processes using knowledge previously gleaned from
S. cerevisiae. We found that most of the genes involved in FA transport
and activation in S. cerevisiae are conserved in Y. lipolytica; however,
both processes appear to be more complex in Y. lipolytica. To decipher
the role of these cellular mechanisms, we inactivated all the genes
potentially involved in FA transport and activation in Y. lipolytica and
analyzed their genetic interactions. We found that YlPxa1p/YlPxa2p,
a homologue of ScPxa1p/ScPxa2p, may function as heterodimer; it ap-
pears to be involved in MCFA and short-chain fatty acid (SCFA) trans-
port in addition to LCFA transport. Moreover, the deletion of YlANT1
decreased yeast growth on SCFAs and LCFAs, and the mutant did not
grow at all on C10:0 FAs, which suggests that the activation of these
FAs also takes place in the peroxisomes. The absence of YlPXA1,
YlPXA2, and YlANT1 dramatically decreased yeast growth on SCFAs,
MCFAs, and LCFAs. We also found that YlFaa1p is responsible for exog-
enous FA accumulation and that the deletion of YlPXA1, YlPXA2, and/or
YlANT1 increased FA accumulation when cells were grown in an oleate
medium. Based on our results, we propose a model for FA transport
and activation in different cellular compartments in Y. lipolytica.
2. Material and methods
2.1. Yeast strains and culture conditions
The Y. lipolytica strains used in this study were derived from the
wild-type Y. lipolytica strain W29 (ATCC20460) (Table 1). Theauxotrophic strain used here, Po1d (Leu− Ura−), was previously de-
scribed by [2]. All the strains used in this study are listed in Table 1.
The media and growth conditions for Escherichia coli in this study are
the same as those of [47], and the conditions for Y. lipolytica are the
same as those of [2]. Rich medium (YPD) and minimal glucose medium
(YNB)were prepared as described in [33]. The YNBmedium contained a
0.17% (wt/vol) yeast nitrogen base (without amino acids or ammonium
sulfate, YNBww; Difco, Paris, France), 0.5% (wt/vol) NH4Cl, and a 50mM
phosphate buffer (pH 6.8). As necessary, the YNB medium was supple-
mented with uracil (0.1 g/L) and/or leucine (0.1 g/L). The YNBD0.5O3
medium contained 0.1% (wt/vol) yeast extract (Bacto-BD), 0.5% glucose,
and 3% oleic acid. Solid media were created by adding 1.6% agar. The
YNBC0 medium was prepared in the same way as the YNB medium
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cluded in liquid or solid media, a 50:50 emulsion of fatty acids/10%
pluronic acid was prepared and then heated at 80 °C for 10 min before
being added to the media. The following fatty acids were used in our
study: C6:0 (Sigma Aldrich, 99%), C10:0 (Sigma Aldrich, 99%), and
C18:1 (Sigma Aldrich, 70%). YNBD0.5O3 and YNBC0 media were used
for the lipid accumulation and lipid remobilization experiments,
respectively.
2.2. Construction of plasmids and strains
Primarily, the deletion cassetteswere generated using PCR ampliﬁca-
tion according to the procedure used by [15]. First, the upstream (Up or
P) and downstream (Dn or T) regions were ampliﬁed from Y. lipolytica
W29 genomic DNA; they were used as templates and the gene-speciﬁcTable 2
List of primers.
Genes Primers Sequences
YlPXA1
YlPXA2
A06655Up2NotI GAATGCGGCCGCCCTTTCATATGGAATGCTCACCA
A06655Up2IsceI CGATTACCCTGTTATCCCTACCGGGGTCTTGAGAGC
A06655Dn2NotI GAATGCGGCCGCCAATTGCAGCACCCAGGATTCTC
A06655Dn2IsceIIceuI GGTAGGGATAACAGGGTAATCGTAACTATAACGG
GATTCCTGTTTGTATGTATGTTCGC
Ver1A06655 CTCAGCCTCTGATAGCGTGG
Ver2A06655 AGCAAGTTACGCCTTACACC
A06655BamHI2 ATCGGATCCCACAATGGCAAACGTCTCTACACTACG
A06655Rbis CCACACTCAGACGAGCCTCCTTGGAACCCACAATCT
A06655Fbis GGACTGGGATCTTGAGATTGTGGGTTCCAAGGAGG
A06655AvrIIF CATCCTAGGTTCTTCTCGGACTTCTTGGGATTGCTA
A06655F GGAAGGATGTCTTTTCTGG
A06655R AAGGTCGATGAGATATGGTG
D04246UpNotI GAATGCGGCCGCATGGCATACATCACTTGTCC
D04246UpIsceI CGATTACCCTGTTATCCCTACCGTTTTGAGACGGTC
D04246DnNotI GAATGCGGCCGCGCCACCAACTTCTCTTACTG
D04246DnIsceIIceuI GGTAGGGATAACAGGGTAATCGTAACTATAACGG
GCGAAGATTACGACG
Ver1D04246 CGTCATTGTTGTTCTCCTGG
Ver2D04246 TCGGCTACTACCCTGGCGTC
D04246BamHI2 ATCGGATCCCACAATGGACCGTCTCAAAACGTCGG
D04246AvrIIF2 CATCCTAGGTGAGCAACAGACGCCTTGAGCATTGC
D04246F TTCTACCACAAGCCGAAG
D04246R TCGCCAAAGAGATAACCA
YlFAA1 D17864UpNotI GAATGCGGCCGCTGCTCATCTCACTCGTACGC
D17864UpIsceI CGATTACCCTGTTATCCCTACCCCATTCTTTGTTAGT
D17864DnNotI GAATGCGGCCGCATCTTCCATCGATACCAACC
D17864DnIsceIIceuI GGTAGGGATAACAGGGTAATCGTAACTATAACGG
GCAGTCTTAGAGTGTT
Ver1-1D17864 GCCAATGGTTGCGCATTTCCCGG
Ver2-2D17864 GTTCCAGCAACAGACTGACAGC
D17864BamHI2 ATCGGATCCCACAATGGTCGGATACACAATTTCCTC
D17864AvrII2 CATCCTAGGGACTGCTCGTAGCACTCATCAATTTCC
D17864F GTGATATTGCCGAGTGGA
D17864R CTCGTTAGGAATGACCAGAG
YlANT1 E03058UpNotI GAATGCGGCCGCACGTGCGATCTGTGGATTTC
E03058UpIsceI CGATTACCCTGTTATCCCTACCTGAGTGAGATGGGT
E03058DnNotI GAATGCGGCCGCCCATAGTGGCCAGTCATC
E03058DnIsceIIceuI GGTAGGGATAACAGGGTAATCGTAACTATAACGG
TAAGAATAGACAAGAC
Ver1E03058 CCGTTCTGCTCCAGGGTAAC
Ver2E03058 ACACTCTTATGCCGGACCGC
E03058FYFP2 CGGCATGGACGAGCTGTACAAGATGGCAGCTATTT
E03058AvrII3 CATCCTAGGTTATCCCTTGATCAAGGTGGGGGCCT
YFPBamHI2 ATCGGATCCCACAATGAAGCTTCCCCGCGGCCTAG
YFPFE03058 CATAGTCTTTGGAAATAGCTGCCATCTTGTACAGCT
E03058F TCCCTCTTGTCTTCTAGGTGT
E03058R AGTCTGCTGTCGTGTGGT
ACTIN ACT-A1 TCCAGGCCGTCCTCTCCC
ACT-A2 GGCCAGCCATATCGAGTCGCA
ALG9 ALG9-A1 AGTATCCCTCTGCACATGA
ALG9-A2 TTGGCAGGAATATCGATGTC
pTEF-start GGGTATAAAAGACCACCGTCC
61 stop GTAGATAGTTGAGGTAGAAGTTGUp and Dn oligonucleotides served as primer pairs (Table 2). The
primers UpISceI or P2IsceI and DnIsceI or T1IsceI contained extensions
used to introduce the I-SceI restriction site that allowed an UpDn frag-
ment to be constructed employing PCR fusion (see above).
To disrupt YlANT1 (YALI0E03058), the primer pairs E03058UpNotI/
E03058UpIsceI and E03058DnNotI/E03058DnIsceIIceuI were used
(Table 2). The Up and Dn regions were puriﬁed and then used for the
PCR fusion. The resulting UpDn fragment was ligated into pCR4Blunt-
TOPO, yielding the strain JMP1644. The URA3 and LEU2markers (from
JMP802 and JMP803) were then introduced at the I-SceI site, yielding
JMP1677 and JME1842, which contained, respectively, the YlANT1::URA3
and YlANT1::LEU2 cassettes. The deletion cassettes were released from
the plasmids by NotI digestion.
To disrupt YlFAA1 (YALI0D17864), the primer pairs D17864UpNotI/
D17864UpIsceI and D17864DnNotI/D17864DnIsceIIceuI were usedUtilization
CACC Upstream fragment of YlPXA1
TGTGGCTAC
G Downstream fragment of YlPXA1
TCCTAAGGTAGCGATATC
Veriﬁcation of disruption
ACCGCTGCTCATCGAGG Construction of the YlPXA1-YFP fusion in JMP1427
CAAGATCCCAGTCC
CTCGTCTGAGTGTGG
GTCTTGG
YlPXA1 expression by RT-PCR
Upstream fragment of YlPXA2
CATCTG
Downstream fragment of YlPXA2
TCCTAAGGTAGCGAGGGT
Veriﬁcation of disruption
CTGTGGGC Construction of the YlPXA2-YFP fusion in JMP1427
TAGACGTTCTTCC
YlPXA2 expression by RT-PCR
Upstream fragment of YlFAA1
TGTTGG
Downstream fragment of YlFAA1
TCCTAAGGTAGCGACGA
Veriﬁcation of disruption
AAAGCCCG Construction of the YlFAA1-YFP fusion in JMP1427
TTCTTG
YlFAA1 expression by RT-PCR
Upstream fragment of YlANT1
GAGTTG
Downstream fragment of YlANT1
TCCTAAGGTAGCGACAAGGGA
Veriﬁcation of disruption
CCAAAGACTATGTTCTGTCG Construction of the YlANT1-YFP fusion protein
TCATG
G
CGTCCATGCCG
YlANT1 expression by RT-PCR
Actin expression by RT-PCR
ALG9 expression by RT-PCR
Veriﬁcation of the insertion of the overexpression
cassette into the Y. lipolytica genome
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PCR fusion. The resulting UpDn fragment was ligated into pCR4Blunt-
TOPO, yielding JMP1643. The URA3 marker (from JMP803) was then
introduced at the I-SceI site, yielding JMP1675, which contained the
YlFAA1::URA3 cassette. The deletion cassettes were released from the
plasmids by NotI digestion.
To disrupt YlPXA1 (YALI0A06655), the primer pairs A06655Up2NotI/
A06655UpIsceI and A06655Dn2NotI/A06655Dn2IsceIIceuI were used
(Table 2). The Up and Dn regions were puriﬁed and then used for the
PCR fusion. The resulting UpDn fragment was ligated into pCR4Blunt-
TOPO, yielding JMP1633. The URA3 marker (from JMP803) was then
introduced at the I-SceI site, yielding JMP1697, which contained the
YlPXA1::URA3 cassette. The deletion cassettes were released from the
plasmids by NotI digestion.
To disrupt YlPXA2, the primer pairs D04246UpNotI/D04246UpIsceI
and D04246DnNotI/D04246DnIsceIIceuI were used (Table 2). The Up
and Dn regions were puriﬁed and then used for the PCR fusion. The
resulting UpDn fragment was ligated into pCR4Blunt-TOPO, yielding
JMP1637. The URA3 and LEU2 markers (from JMP802 and JMP803)
were then introduced at the I-SceI site, yielding JMP1673 and
JME1765, which contained, respectively, the YlPXA2::URA3 and
YlPXA2::LEU2 cassettes. The deletion cassettes were released from the
plasmids by NotI digestion.
Cassettes for the complementation of ΔYlant1, ΔYlpxa1, ΔYlpxa2,
and ΔYlfaa1 were constructed using the primer pairs E03058Start/
E03058End, A06655BamHI2/A06655AvrIIF, D04246BamHI2/
D04246AvrIIF2, and D17864BamHI2/D17864AvrII2, respectively. The
YlPXA1 ORF was acquired by the fusion of two PCR fragments obtained
with primer pairs A06655BamHI2/A06655Rbis and A06655Fbis/
A06655AvrIIF. The YlANT1 ORF was cloned into pCR4Blunt-TOPO
(JME1934) and then digested by AvrII and BamHI. It was then cloned
into a form of JMP1394 previously digested by BamHI and AvrII to
yield JME2025. The PCR fragments of the other genes were digested
by BamHI and AvrII and cloned into JMP1427 to yield JMP2384,
JMP2387, and JMP2390, respectively.
Transformation involving the disruption or overexpression cassettes
was performed using the lithium acetate method [30]. Transformants
were selected on YNBcasa, YNBura, or YNBmedia, depending on the ge-
notype of interest. Then genomic DNA from the yeast transformants
was prepared as described by [40]. The corresponding ver1 and ver2
primers (Table 2) were used to verify gene disruption, and the pTEF
start and 61 stop primers were used to verify integration of the overex-
pression cassette. To deletemore than two genes, markers were excised
using JMP547 as already described in [15].
Restriction enzymes were obtained fromOZYME (Saint-Quentin-en-
Yvelines, France). The PCR ampliﬁcations were performed using an
Eppendorf 2720 thermal cycler and employing GoTaq DNA polymerases
(Promega, Madison, WI) for PCR veriﬁcation and PyroBest DNA poly-
merases (Takara, Saint-Germain-en-Laye, France) for cloning. The PCR
fragments were puriﬁed using a QIAgen Puriﬁcation Kit (Qiagen, Hilden,
Germany), and theDNA fragmentswere recovered from the agarose gels
using a QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany). Amount
of DNA were measure by a MySpec (VWR, Fontenay-sous-Bois, France).
All the procedures were carried out in accordance with the manufac-
turers' instructions. The Clone Manager software package was used for
the gene sequence analysis (Sci-Ed Software, Morrisville, NC).
2.3. Gas chromatography
Lipidswere extracted from 10–20mg aliquots of cells and converted
into their equivalentmethyl esters using the procedure described in [7].
The products were then used in the gas chromatography analysis. This
analysis was performed using a Varian 3900 gas chromatograph
equipped with a ﬂame ionization detector and a Varian FactorFour
vf-23 ms column, where the bleed speciﬁcation at 260 °C was 3 pA
(30 m, 0.25 mm, 0.25 μm). FA were identiﬁed by comparison withcommercial fatty acid methyl ester standards (FAME32, Supelco) and
quantiﬁed by the internal standard method with the addition of 50 μg
of commercial C17:0 (Sigma, Saint-Quentin Fallavier, France).2.4. FFA and TAG amounts determination
Lipids from aliquots of 10 mg of cells were extracted by the proce-
dure of Folch et al. [61] for HPLC analysis. Lipid species were analyzed
using a gradient reversed phase HPLC (Ultimate 3000, Dionex-Thermo
Fisher Scientiﬁc, UK) using an AcclaimTM 120 C8 3 μm 120 Å coupled
to a Corona Veo detector. The columnwas elutedwith a binary gradient
solution (Table S1) at 40 °C and a constant ﬂow rate of 0.8 ml min−1.
Identiﬁcation and quantiﬁcation were achieved via comparisons to
standards.2.5. Analysis of the expression of YlPXA1, YlPXA2, YlANT1, and YlFAA1
To determine if oleate induced the expression of YlPXA1, YlPXA2,
YlANT1, and YlFAA1, precultures of the reference strain (JMY2900)
were set up in liquid YNB, supplemented with 1% glucose and 0.5%
yeast extract, and grown for 15 h at 28 °C. Cells were washed with dis-
tilled water and transferred to a fresh liquid YNBmedium supplement-
edwith 1% glucose, 3% oleate, or both 1% glucose and 3% oleate. Cultures
were grown in bafﬂed Erlenmeyer ﬂasks kept at 28 °C and 160 rpm.
Cells were harvested at 2 and 6 h post inoculation, frozen in liquid nitro-
gen, and stored at−80 °C. RNA was extracted from the cells using the
RNeasy Mini Kit (Qiagen, Hilden, Germany), and 2 μg were treated
with DNAse (Ambion, Life Technologies, Saint Aubin, France). cDNA
was synthesized using the SuperScript III First-Strand RT-PCR Kit
(Invitrogen, Saint Aubin, France). PCR was then performed using the
GoTaq DNA Polymerase Kit (Promega, Madison, W) employing speciﬁc
primers designed by the Primer3 program (see Table 2).2.6. Microscopic analysis
Images were acquired using a Zeiss Axio Imager M2 microscope
(Zeiss, Le Pecq, France) equipped with a 100× objective lens and Zeiss
ﬁlters 45 and 46 for ﬂuorescent microscopy. Axiovision 4.8 software
(Zeiss, Le Pecq, France) was used for image acquisition. Lipid bodies
were visualized after adding BodiPy® Lipid Probe (2.5mg/ml in ethanol;
Invitrogen, Saint Aubin, France) to the cell suspension (A600 of 5) and
after incubating the cells at room temperature for 10 min. The LIVE/
DEAD BacLight Bacterial Viability Kit (Life Technologies) was used as
per the manufacturer's instructions to count living and dead cells
under the microscope.2.7. In silico ﬂux balance analysis
Flux balance analysis calculations were performed using MATLAB
(Mathworks, Natick, MA) and the Raven toolbox [1]. To determine if
the model can predict growth the reaction ‘BiomassEx’ was set as the
objective function and the system of linear equations was solved. Fatty
acids uptake (C18:1, C10 and C6) were constrained to 1 mmol/gh.
For analyzing the capacity to produce lipid bodies, the reaction
‘LipidBodyExcretion’ was the objective function. In order to simulate
the different knock outs strains the ﬂux carried by the reactions associ-
ated to the studied genes (ant1, faa1, pxa1, pxa2 and fat1) were set
to zero. The absences of ﬂuxes in the reactions to produce biomass
or lipid bodies were associated to the incapability of that genotype
either to grow or to produce lipid bodies. The Biomet toolbox 2.0
(http://biomet-toolbox.org/) on line tool was used to check the ﬂux
balance analysis [22].
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3.1. Transport and activation mechanisms found in S. cerevisiae are
conserved in Y. lipolytica
In order to know if Y. lipolytica contains the same set of FA transport
and activation genes as S. cerevisiae, we searched for gene homologues.
Although S. cerevisiae possesses four Faap proteins as well as one Fat1p
and one Ant1p protein, Y. lipolytica has only one Faap protein, one Fat1p
protein [12], and three potential Ant1p proteins. Indeed, YlAnt1p
(YALI0E3058p) has two homologues in Y. lipolytica: YALI0A20944p
(34% shared identity) and YALI0C06127p (32% shared identity). Accord-
ing to annotation data, YALI0A20944p is related to the peroxisomal
membrane protein PMP47B found in Neurospora crassa (Génolevure),
which is involved in peroxisomemetabolism [46], and YALI0C06127p is re-
lated to Flx1p in S. cerevisiae (Génolevure), a carrier protein involved in
maintaining a proper balance of ﬂavin nucleotides in mitochondria [56].
To expand our search, we looked for ScPxa1p and ScPxa2p ho-
mologues in the Y. lipolytica genome. Blast analysis revealed that
Y. lipolytica possesses two proteins, YALI0A06655p (which has been
named YlPxa1p) and YALI0D04246p (which has been named YlPxa2p),
that are homologous to ScPxa1p (41% shared identity) and ScPxa2p
(35% shared identity), respectively. The alignments of YlPxa1p with
ScPxa1p and Ylpxa2p with ScPxa2p are shown in Figs. 1 and 2. As for
ScPxa1p, ﬁve transmembrane domains (TMs) were predicted by
TMHMM for YlPxa1p (Fig. 1); only four were predicted for YlPxa2p
based on the ﬁve identiﬁed for ScPxa2p (Fig. 2). The residues most con-
served between YlPxa1p and ScPxa1p are found in the following areas:
loop 1, the EAA-like motif (found in some transporters), the Walker A
and B motifs (generally found in transporters), and the C sequence
(sequence located immediately after the N-terminal of the Walker B
motif). It has been shown that highly conserved residues like E294
(E357 for YlPxa1p and E406 for ScPxa1p; Fig. 1) and G301 (G364 for
YlPxa1p and G413 for ScPxa1p; Fig. 1) of the EAA motif and R108
(R173 for YlPxa1p and R220 for ScPxa1p; Fig. 1) of loop 1 are essential
for ScPxa1p activity [49]. These amino acid sequences are conserved
not only in Y. lipolytica and S. cerevisiae, but also in the human homo-
logue of ScPxa1p: ABCD1 (also called ALDP). Indeed, mutations of
these residues are associated with adrenoleukodystrophy (Fig. 1;
[49]); other mutations in the human form of Pxa1p, such as the trans-
formation of a Gly512 residue into a Ser (e.g., G601 in YlPxa1p) or a
Ser606 residue into a Leu (e.g., S695 in YlPxa1p), decrease ATPase activ-
ity and ATP binding afﬁnity, respectively (www.uniprot.org/uniprot/
P33897). Surprisingly, analyses of YlPxa2p by Mitoprot predicted a pu-
tative mitochondrial localization with the following mitochondria-
targetting sequence MDRLKTSAVGQKVVSYVSARSPVWGATYLRH (Fig. 2).
3.2. Expression of YlANT1, YlPXA1, YlPXA2, and YlFAA1 is induced by oleate
We had already found that the expression of YlFAT1 and YlPEX11,
two genes involved in lipid metabolism, is induced by oleic acid ([12];
unpublished data). In order to determine if the expression of YlANT1,
YlPXA1, YlPXA2, and YlFAA1 is also regulated by oleic acid, we used the
following procedure. Y. lipolytica cells were grown in YNB medium
containing 1% glucose; they were then transferred to YNB medium
supplemented with 1% glucose or 3% oleate, or both 1% glucose and 3%
oleate. RT-PCR analysis performed after 2 and 6 h of growth indicated
that (i) YlANT1, YlPXA1, YlPXA2, and YlFAA1 were expressed under all
the conditions tested and (ii) these genes were upregulated in media
containing oleate (Fig. 3). These results are similar to those obtainedFig. 1.Alignment of YlPxa1pwith ScPxa1p. The alignmentwas performedusing ClustalW. The y
theWalker Amotif; the black frame to the C sequence; and the orange frame to theWalker Bmo
residues found in people afﬂictedwith peroxisome Pxa1 disease (www.uniprot.org/uniprot/P33
brane domains (TMs) in YlPxa1p and ScPxa1p, respectively; these were identiﬁed using TMH
YlPxa1p and from 0.7 to 1 for ScPxa1p.for S. cerevisiae cultivated in oleic acid [45,51,57]. Moreover, our results
show that the presence of glucose does not repress the upregulation of
these genes by oleate and strongly suggest that YlAnt1p, YlPxa1p,
YlPxa2p, and YlFaa1p play a role in oleate utilization.
3.3. Localization of YlPxa1p, YlPxa2p, and YlFaa1p
In S. cerevisiae, ScPxa1p, ScPxa2p, and ScAnt1p are found in peroxi-
somes [19,49,52], while ScFaa1p is found in the plasma membrane,
lipid particles, mitochondria, and the endoplasmic reticulum [6,19,36].
To determine whether YlPxa1p, YlPxa2p, YlAnt1p, and YlFaa1p occur
in those same locations in Y. lipolytica, four YFP fusion proteins were
added to the C-terminals of YlPxa1p, YlPxa2p, and YlFaa1p (YlPxa1-
YFPp, YlPxa2-YFPp, and YlFaa1-YFPp) and the N-terminal of YlAnt1p
(YFP-YlAnt1p). We could not characterize the localization patterns
of YlAnt1p because we could not obtain a functional fusion protein
(data not shown). All the other constructs were functional and com-
plemented the original phenotype (see above as well as Figs. 8 and 9).
YlPxa1-YFPp and YlPxa2-YFPp are localized in peroxisome (Fig. 4). Con-
ﬁrmation of peroxisomal localisation was obtained by introducing
a RedStar2SKL, which targets peroxisome, into these strains since co-
localisation of both tagged-proteins was observed (Fig. 4). Our results
also show that, contrary to Mitoprot's prediction, YlPxa2p is not found
in mitochondria. YlFaa1-YFPp occurred around lipid bodies, cytoplasm
and in the vacuole (Fig. 4). It is most likely that partial YlFaa1-YFPp ac-
cumulation in the vacuole is due to its overexpression. These results
suggest that FA activation in the cytoplasm and FA transport into the
peroxisomes could be similar in Y. lipolytica and S. cerevisiae.
3.4. YlANT1, but not YlPXA1, YlPXA2, or YlFAA1, is essential for growth on FAs
To analyze the role of YlANT1, YlPXA1, YlPXA2, and YlFAA1 in FA utili-
zation, single mutants were constructed (JMY3237, JMY3230, JMY3233,
and JMY3234, respectively). All themutants grewaswell as the reference
strain (JMY2900) in the presence of glucose (data not shown). The
growth capacity of these strainswas testedusing plates containing differ-
ent FAs—C6:0, C10:0, and C18:1—and dicarboxylic acid (DC18:1), as the
sole carbon source. Y. lipolytica is able to degrade and to produce dicar-
boxylic acids [17,50,53]. It was also show previously that the acyl-CoA
oxydases Aox1p and Aox2pwere involved in dicarboxylic acids degrada-
tionwhile Aox2p to Aox5pwere involved in fatty acids degradationwith
a chain-length speciﬁcity [53,55]. Therefore the dicarboxylic acid CD18:1
was included in this study. Surprisingly,ΔYlpxa1 and ΔYlpxa2 grew as well
as the parental strain (Fig. 5), suggesting that at least one other protein is
present and compensates for the absence of YlPxa1p or YlPxa2p. This
could include transporters of activated or unactivated FAs; however, in
this later case, this ﬁnding means that FA activation takes place in the per-
oxisomes. Moreover, since ScPxa1p and ScPxa2p form a heterodimer in
S. cerevisiae [19,52], another hypothesis that could explain our results is
that, in Y. lipolytica, YlPxa1p or YlPxa2p form a functional homodimer and
that the absence of one protein is compensated for by the presence of the
other. This last hypothesis is possible since the Pxa1 and Pxa2 human
homologues—ABCD1, ABCD2, and ABCD3—function as homodimers [31,
42,43,62].
Interestingly,ΔYlant1 failed to grow at all on C10:0; its growth dem-
onstrated a strong decrease on C6:0 and DC18:1 and a slight decreases
on C18:1 (Fig. 5). A slight decrease in growth associated with C18:1
was also observed when the mutant was grown in a liquid medium
(Fig. S1A). To conﬁrm that the phenotype of the ΔYlant1 mutant was
really due to the gene deletion, complementation was performed byellow frame corresponds to loop 1; the blue frame to the EAA-likemotif; the green frame to
tif (from [49]). The residues that are underlined and in slightly bigger font are themutated
897). The black lines and the green lines indicate the positions of the potential transmem-
MM v.2 (www.cbs.dtu.dk/services/TMHMM/). Their probabilities range from 0.8 to 1 for
Fig. 2.Alignment of YlPxa2pwith ScPxa2p. The alignmentwas performedusing ClustalW. The arrow indicates the potential cleavage site for themitochondria-targeting sequence given by
Mitoprot (http://ihg.gsf.de/ihg/mitoprot.html). The black lines and the green lines indicate the positions of the potential transmembrane domains (TMs) in YlPxa2p and ScPxa2p, respec-
tively; these were identiﬁed using TMHMM v.2 (www.cbs.dtu.dk/services/TMHMM/). Their probabilities range from 0.9 to close to 1 for YlPxa2p and from 0.3 to 0.8 for ScPxa2p.
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the mutant strain was able to grow as the parental strain on all the FAs
tested (data not shown). These results show thatMCFA (C10:0 here) are
only activated in the peroxisomes, as previously demonstrated in
S. cerevisiae, where ScAnt1p was necessary for yeast growth on C8and C12 [38,41]. These results concur with those obtained by [54]: me-
dium-chain alkanes (C10 and C11) require the presence of YlAnt1p to
be consumed.
The deletion of YlFAA1 had little to no effect on yeast growth on FAs
excepted on C18:1 (Fig. 5 and Fig. S1A). Althoughwe cannot exclude the
Fig. 3. Expression proﬁles for YlFAA1, YlPXA1, YlPXA2, and YlANT1 in presence of glucose and/or oleate. Cellswere precultured in liquid YNB supplementedwith 1% glucose and 0.5% yeast
extract for 15 h at 28 °C (T0). Cellswere then transferred to a fresh liquidYNBmedium supplementedwith 1% glucose, 3% oleate, or both 1%glucose and 3%oleate and incubated for 2 or 6 h
at 28 °C. The expression proﬁles of Actin and ALG9were used as endogenous controls for all the conditions tested. RT- and gDNA served as the negative and positive controls, respectively.
1209R. Dulermo et al. / Biochimica et Biophysica Acta 1851 (2015) 1202–1217possibility that another protein is compensating for YlFaa1p and is able
to activate FAs in cytoplasm, this result may suggest that unactivated
FAs of varying chain length are being transported into the peroxisomes
and activated in this organelle.
In conclusion, in contrast to what was seen in S. cerevisiae, activation
takes place in the peroxisomes mainly for C6:0, C10:0 and DC18:1 and
partially for C18:1. Additionally, all these results suggested that peroxi-
somes contain transporters of non-activated FAs as proposed above andFig. 4. Localization patterns of YlFaa1p, YlPxa1p, and YlPxa2p fused to YFP. The locations of (A)
on YNBD0.5O3. Peroxisomes were stained by a peroxisome-targeting ﬂuorescent protein, RedStactivation of FA in peroxisome is a major way compares cytoplasmic FA
activation.
3.5. Deleting YlANT1 from ΔYlpxa1 and ΔYlpxa2 had a synergistic effect on
yeast growth on fatty acids
To decipher whether YlPxa1p and YlPxa2p work as homodimers or
heterodimers, a double mutant—ΔYlpxa1 ΔYlpxa2—was constructedYlFaa1-YFPp, (B) YlPxa1-YFPp, and (C) YlPxa2-YFPpwere determined after 24 h of growth
ar2SKLp.
Fig. 5. Growth of the reference strain (JMY2900) and various mutants (ΔYlfaa1, ΔYlant1,
ΔYlpxa1, ΔYlpxa2, andΔYlpxa1ΔYlpxa2) on different carbon sources (0.2%). The following
carbon sources were used: glucose; methyl caproate (C6:0); methyl decanoate (C10:0);
oleate (C18:1); and octadecenedioic acid (DC18:1). Pictures were taken after 3 days of
growth at 28 °C and show representative results from the three independent experiments.
Fig. 6. Growth of JMY2900, ΔYlpxa1, ΔYlpxa2, ΔYlpxa1 ΔYlpxa2, ΔYlpxa1 ΔYlant1, ΔYlpxa2
ΔYlant1, and ΔYlpxa1 ΔYlpxa2 ΔYlant1 on different carbon sources (0.2%). The carbon
sources are the same as in Fig. 5. Pictures were taken after 3 days of growth at 28 °C and
show representative results from the three independent experiments.
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on C6:0, C10:0, C18:1 and DC18:1 (Fig. 6 and Fig. S1C). This result con-
ﬁrms that FAs aremainly being activated in the peroxisomes, unless an-
other transporter is compensating for the absence of YlPxa1p/YlPxa2p.
If YlPxa1p and YlPxa2p are exclusively responsible for the transport
of activated FAs into the peroxisomes, then the deletion of YlANT1
from theΔYlpxa1 andΔYlpxa2mutants would be predicted to drastical-
ly decrease the mutants' ability to grow on FAs. To test this hypothesis,
two double mutants—ΔYlpxa1 ΔYlant1 (JMY3797) and ΔYlpxa2 ΔYlant1
(JMY3811)—and a triple mutant—ΔYlpxa1 ΔYlpxa2 ΔYlant1 (JMY3795)—
were constructed. As expected, synergic effect of these mutations was
observed, especially for C18:1 since growth on FAs was stronglyaffected for all three mutants (Fig. 6 compare Fig. 5 and Fig. S1D).
Since similar results were obtained with these mutants, this strongly
suggests that YlPxa1p and Ylpxa2p may function as heterodimer as
their homologue in S. cerevisiae [19,52].
3.6. YlFaa1p is the only cytoplasmic acyl-CoA synthetase in Y. lipolytica
To determine if there are other proteins that YlFaa1p could activate
cytoplasmic FAs, we constructed a strain devoid of YlANT1 and YlFAA1
1211R. Dulermo et al. / Biochimica et Biophysica Acta 1851 (2015) 1202–1217(JMY3464). If YlFaa1p is the only cytoplasmic acyl-CoA synthetase, this
strain should not grow on FAs since no activation of FA is possible in this
strain. No growth was observed on C6:0, C10:0, C18:1, and DC18:1
(Fig. 7), showing that Y. lipolytica has only one cytoplasmic acyl-CoA
synthetase, YlFaa1p.
3.7. In Y. lipolytica, decreased uptake of FAs into the peroxisomes leads to
increased lipid accumulation
Y. lipolytica is an oleaginous yeast that is able to accumulate lipids in
lipid bodies. Strains in which β-oxidation has been impaired—such
as strains whose acyl CoA oxidases have been eliminated (Pox1-6p;
enzymes involved in FA degradation, [33])—or strains inwhich remobi-
lization processes have been affected—such as ΔYlfat1 [12] or Δtgl4 [10,
11]—accumulate greater quantities of lipids thandowild type strains. To
analyze the impact of deleting YlANT1, YlFAA1, YlPXA1, and YlPXA2 on
lipid accumulation, we performed a set of experiments in which we
grew mutants in a medium that favors lipid accumulation, YNBD0.5O3.
Fluorescent staining of lipids clearly showed that all the mutants fromFig. 7. Growth of JMY2900, ΔYlfaa1, ΔYlant1, and ΔYlfaa1 ΔYlant1 on various carbon
sources (0.2%). The carbon sources are the same as in Fig. 5. Pictures were taken after
3 days of growth at 28 °C and show representative results from the three independent
experiments.whichYlPXA1 and YlPXA2 had beendeleted contained larger lipid bodies
than did the reference strain, JMY2900 (Fig. 8D, E, F, H, I, J, L and M vs.
Fig. 8A). Moreover, the deletion of YlANT1 increased the number and
size of lipid bodies onlywhen YlPXA1 and/or YlPXA2had also been delet-
ed; in suchmutants, lipid bodies ﬁlledmost of the cell (Fig. 8H, I, J, M vs.
Fig. 8A and B). Moreover, although the viability of the ΔYlpxa1 ΔYlpxa2
and ΔYlant1mutants was similar to that of JMY2900 (99.3% survival) in
YNBD0.5O3 (data not shown), the viability of the ΔYlpxa1 ΔYlpxa2
ΔYlant1mutantwas severely affected since only 50% of its cells survived
24 h of culture (Fig. 8J and Fig. S2). The loss of viability in the ΔYlpxa1
ΔYlpxa2 ΔYlant1mutant was unexpected andmay be linked to a dereg-
ulation of lipid homeostasis. Interestingly, there was a synergistic effect
when YlFAT1was deleted at the same time as YlPXA1 and YlPXA2—more
and larger lipid bodieswere observed in the triplemutant (Fig. 8L andM
vs. Fig. 8J).
In order to conﬁrm that greater lipid body size and number was cor-
related with a higher level of lipid accumulation, gas chromatography
was carried out on all the mutants. Indeed, while lipid accumulation
attained 24% of CDW in JMY2900, accumulation levels were around
35–37% of CDW in ΔYlpxa1 and/or ΔYlpxa2 and reached 42–53% of
CDW in ΔYlpxa1 and ΔYlpxa2 strains from which YlANT1 and/or
YlFAT1 had also been deleted (Fig. 9).
We wish to underscore that the deletion of YlFAA1 strongly reduced
lipid accumulation (Figs. 8C and 9), which demonstrates that, in
Y. lipolytica, cytoplasmic activation is a necessary step in the storage of
exogenous FAs in lipid bodies. In theΔYlfaa1mutant, lipid accumulation
only reached about 8% of CDW, which corresponds to FA neosynthesis.
In addition, the morphology of the ΔYlant1 ΔYlfaa1 mutant indicates
that most of its cells died (Fig. 8G): CFU analysis conﬁrmed that about
95% of the cells died after 24 h of culture in the YNBD0.5O3 medium
(data not shown). This result explains why the cells did not grow on
FAs—at least in the case of C18:1: a toxic effect manifested itself in this
mutant because its cells were unable to activate the FAs. Therefore,
the vulnerability of the ΔYlant1 ΔYlfaa1 mutant to FAs may explain
the excess of free fatty acids (FFAs) in its cytoplasm. Indeed, ΔYlant1
ΔYlfaa1 accumulated (without any visible lipid bodies) slightly more
lipids than did JMY2900 (31% vs. 24%; Fig. 9). However, as just ex-
plained, this result could stem from the presence of FFAs.
All these results suggest that FAs activated by YlFaa1p are partially
stored in lipid bodies. Moreover, when FAs cannot rapidly enter perox-
isomes (i.e., in the case of the ΔYlpxa1, ΔYlpxa2 mutants), they are
directed toward the storage pathway. It is unlikely that the second path-
way, in which unactivated FAs enter the peroxisomes, could handle all
the FAs coming into the cell under such conditions. This issue could ex-
plainwhy theΔYlant1mutant accumulated lipids at only slightly higher
levels than did JMY2900 (Fig. 9). Additionally, when the entry of the
activated FAs into the peroxisomes (as in the ΔYlpxa1 and/or ΔYlpxa2
mutants) and peroxisomal activation (in the ΔYlant1mutant) are im-
paired, FAs are activated by YlFaa1p in the cytoplasm and stored in
lipid bodies in the form of TAGs, which could explain why the ΔYlpxa1
ΔYlpxa2 ΔYlant1mutant overaccumulated lipids. The phenotype dem-
onstrated by strains from which YlPXA1 and YlPXA2 had been deleted
was very similar to what is observed in individuals afﬂicted with
X-linked adrenoleukodystrophy: this disease is characterized by the
increased accumulation of lipids. The only difference between the
ΔYlpxa1 and ΔYlpxa2 mutants and the ΔABCD1 mutant is the kind of
FAs being accumulated: it is LCFAs (C18:1) in Y. lipolytica and very-
long-chain fatty acids (C24:0, C26:0, and C26:1) in humans [24,34,34].
Moreover, lipid accumulation is one of the multiple phenotypes associ-
ated with the deletion of CTS (equivalent to ABCD1) in Arabidopsis
thaliana [16].
3.8.β-oxidation is disturbed inmutant affecting in peroxisomal FA entrance
Previous work by our research group has shown that the FAs accu-
mulated in Y. lipolytica grown on YNBD0,5O3 are a reﬂection of the FAs
Fig. 8.Morphologies of the different strains after 24 h of culture in YNBD0.5O3. (A) JMY2900; (B) ΔYlant1 (JMY3237); (C) ΔYlfaa1 (JMY3234); (D) ΔYlpxa1 (JMY3230); (E) ΔYlpxa1
(JMY3233); (F) ΔYlpxa1 ΔYlpxa2 (JMY3159); (G) ΔYlant1 ΔYlfaa1 (JMY3464); (H) ΔYlpxa1 ΔYlant1 (JMY3797); (I) ΔYlpxa2 ΔYlant1 (JMY3811); (J) ΔYlpxa1 ΔYlpxa2 ΔYlant1
(JMY3795); (K) ΔYlfat1 (JMY3240); (L) ΔYlpxa1 ΔYlpxa2 ΔYlfat1 (JMY4160); and (M) ΔYlpxa1 ΔYlpxa2 ΔYlant1 ΔYlfat1 (JMY4138). TAG ﬂuorescence was obtained by staining cells for
neutral lipids with BodiPy® stain.
1212 R. Dulermo et al. / Biochimica et Biophysica Acta 1851 (2015) 1202–1217present in the medium [3]. The oleic acid used in this study was 73%
C18:1(n−9), 7% C18:2(n−6), 4.7% C16:1(n−7), 3.9% C16:0, 0.9%
C16:1(n−9), and 0.7% C18:0. Interestingly, most of the mutants had
FA proﬁles that differed from that of the reference strain, JMY2900,
especially for C16:0, C16:1(n−7), C16:1(n−9), C18:0 and C18:1
(Fig. 10). No signiﬁcative difference was observed for C18:2, with 10%
of FA for all the studied strains. The ΔYlfaa1mutant contained 3-, 3.3-,
and 2-fold more C16:0, C16:1(n−9), and C18:0, respectively, than the
reference strain (Fig. 10A, B, C). However, it contained only 4.7%
C16:1(n−7) and 60% C18:1(n−9); these values were 8% and 68%,
respectively, for JMY2900. C16:1(n−9) cannot be synthesized by
cells and derives essentially from the degradation of any C18:1(n−9)
present in the medium. The overrepresentation of C16:1(n−9) in the
ΔYlfaa1 mutant may indicate that it had higher levels of β-oxidationFig. 9. FA content of various strains cultivated onYNBD0.5O3. Cells were grown for 24 h onYNBD
were extracted using the procedure described in [7], and FA content was determined using gathan did the reference strain. This explanation also ﬁts well with the
lower levels of C18:1(n−9) observed in this mutant as compared to
JMY2900; FAs may not accumulate in the mutant, resulting in more ac-
cessible FAs for β-oxidation. Although these results were obtained
under different conditions than those of [58] (use of oleate vs. YPD
media, respectively), both sets of ﬁndings show that the deletion of
YlFAA1 can increase the production of C16 FAs and saturated FAs.
ΔYlpxa1, ΔYlpxa2, and ΔYlpxa1 ΔYlpxa2 accumulated 2.5-fold less
C16:1(n−9), 2-fold less C18:0, and 1.5-fold less C16:1(n−7) than did
JMY2900 (Fig. 10B, C). They also accumulated more C18:1(n−9) than
did JMY2900 (around 75–77% vs. 68%; Fig. 10D). All together, these re-
sults suggest that, as previously shown for YlFat1p ([12]; Fig. 9B),
ΔYlpxa1 and/or ΔYlpxa2 are worse at degrading C18:1(n−9). Further-
more, these data conﬁrm that YlPxa1p and YlPxa2p transport C18:10,5O3. These results are themean values± SD from the three independent replicates. Lipids
s chromatography. CDW= cell dry weight.
Fig. 10. FA proﬁles of various strains, expressed as percentages of total FA. (A) C16:0; (B) C16:1(n−7) and C16:1(n−9); (C) C18:0; and (D) C18:1(n−9).
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displayed a more dramatic phenotype. Indeed, compared to JMY2900,
this triple mutant contained 3-fold less C16:0, 6-fold less C16:1(n−9),
5.5−fold less C16:1(n−7), and 3-fold less C18:0 and accumulated up
to 84% of CDW of C18:1(n−9) (Fig. 10). Finally, FA degradation was al-
tered in this triplemutant because the inactivation of YlPXA1 and YlPXA2
reduced the entry of activated FAs into the peroxisomes and the inacti-
vation of YlFAT1 reduced the remobilization of FAs stored as TAGs
in the lipid bodies [12]. Surprisingly, the deletion of YlANT1 from the
wild-type background only weakly affected FA composition. However,when this same gene was deleted from the ΔYlfaa1 background, levels
of C16:0 were increased 1.5-fold whereas levels of C16:1(n−7) and
C16:1(n−9) were reduced 2-fold (Fig. 10). For some unknown reason,
when YlANT1was deleted from the ΔYlpxa1, and/or ΔYlpxa2, or ΔYlpxa1
ΔYlpxa2 ΔYlfat1 backgrounds, levels of C16:1(n−7) increased.
3.9. Remobilization is blocked in the ΔYlpxa1 ΔYlpxa2 ΔYlfat1 mutant
When Y. lipolytica lacks carbon, stored lipids are remobilized. To
determine if one of the genes of interest is involved in this process,
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cultivated in a medium that favored accumulation (YNBD0,5O3),
washed, and then transferred to YNBC0, a medium without a carbon
source. Lipid remobilization was quantiﬁed using gas chromatography
(Fig. 11). As observed by [12], the reference strain, JMY2900, rapidly
remobilized lipids (Fig. 11A). Strains from which YlPXA1, YlPXA2,
YlPXA1 and YlPXA2, or YlANT1 had been deleted had the same remobili-
zation proﬁles as JMY2900, which suggests that these genes are not in-
volved in lipid remobilization or that other genes compensate for their
absence (Fig. 11A). However, a slight decrease in lipid remobilization
was observed when YlANT1 was deleted from the ΔYlpxa1, ΔYlpxa2,
and ΔYlpxa1 ΔYlpxa2 mutants (Fig. 11B). This result indicates that
these genes work together to remobilize lipids but are part of two
different pathways. Since remobilization still occurs in these mutants,
a third lipid remobilization pathway may exist. This last pathway
could be dependent on YlFat1p, which has been shown to be involved
in lipid remobilization [12]. To determine which proteins are the most
important in this process, we examined lipid remobilization in the
ΔYlpxa1 ΔYlpxa2 ΔYlfat1mutant (Fig. 11C). Surprisingly, lipid remobili-
zation was completely absent from this strain. This result could explain
why ΔYlpxa1 ΔYlpxa2 ΔYlfat1 accumulated a very high level of lipids in
Fig. 8. This result shows that YlFat1p, YlPxa1p, and YlPxa2p are, togeth-
er, essential for lipid remobilization. Furthermore, this result suggests
that the YlAnt1p-dependent pathway is of minor importance and that
most of the FAs released are activated by YlFaa1p in the cytoplasm be-
fore they enter the peroxisomes via the heterodimer YlPxa1p/YlPxa2p.Fig. 11. Variation in FA content during lipid remobilization in various strains grown in YNBC0
ΔYlant1; (B) JMY2900, ΔYlpxa1 ΔYlpxa2 ΔYlant1, ΔYlpxa1 ΔYlant1, and ΔYlpxa2 ΔYlant1; (C) JMWe suggest that YlFat1p could be involved in the transport of FAs
from the lipid bodies to the peroxisomes [12]; furthermore, Choi and
Martin [63] showed that ScFat1p demonstrates acyl-CoA synthetase ac-
tivity. This ﬁnding suggests that YlFat1pmay able to activate FAs as they
are being transferred between the lipid bodies and the peroxisomes,
explaining also why YlAnt1p is not really important for remobilization.
4. Conclusion and perspectives
Until now,most studies concerning FA transport and activation have
been performed in the model yeast species S. cerevisae. However, re-
search has recently shown that lipid metabolism differs greatly among
yeast species [11,12,59]. Therefore, it is impossible to make generaliza-
tions about lipid metabolism in yeasts; it cannot be assumed that what
occurs in S. cerevisiae also occurs in other yeasts and, particularly, in ole-
aginous yeasts. Although our study species, Y. lipolytica, does possess FA
transport and activation proteins that are similar to those of S. cerevisiae
(Faa1p, Pxa1p, Pxa2p, Ant1p), we found that FA transport and activation
is actually different in Y. lipolytica than in S. cerevisiae. In fact, our results
suggest that other, unidentiﬁed proteinsmight play an important role in
these processes. Fig. 12 depicts our proposedmodel for FA transport and
activation in Y. lipolytica. External fatty acids (FA ex) enter cells via a sin-
gle ormultiple transporters that remain to be identiﬁed. Internal free FA
(FA in) could bind to the fatty acid binding protein (FABP,❶), activated
by the cytoplasmic YlFaa1p (❷) or transported into peroxisomes (❸)
with chain length preferences. Activated FAs can then be either storedmedium. Lipid remobilization in (A) JMY2900, ΔYlpxa1 ΔYlpxa2, ΔYlpxa1, ΔYlpxa2, and
Y2900 and ΔYlpxa1 ΔYlpxa2 ΔYlfat1. CDW—cell dry weight.
Fig. 12.Model of FA transport and activation in Y. lipolytica. LB, lipid body; (S, M, L) FA, short-, medium-, and long-chain fatty acids, (S, M, L) FA-CoA, short-, medium-, and long-chain
activated fatty acids. The size of the S, M and L indicate the preferred pathways.
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an elongation step) (➍) or they can enter peroxisomes via the heterodi-
mer YlPxa1p/YlPxa2p (❺) and be degraded as a result of β-oxidation
(❻). Unactivated FAs that enter peroxisomes via an unidentiﬁed trans-
porter (❸) are activated by enzymes 4 coumarate CoA ligase (see
below) that required ATP transported by YlAnt1p (❼) (note: this is
the only pathway for MCFA such as C10:0). FAs from TAG are released
from lipid bodies via two principal pathways: one involving YlFat1p
(❽) and another one involving an unidentiﬁed pathway (❾).
Presence of free fatty acid in the cells has been the subject of exten-
sive debate. Several lines of evidences suggest that they are, indeed, free
fatty acid in Y. lipolytica. Thus, there is an increase amount of FFA in cells
deleted for the six acyl-CoA oxidases (pox1-6Δ) and in cells deleted for
the multifunctional enzymeMFE2 (mfe2Δ) [10]. On the opposite, there
is very small amount of FFA in wild-type and in cells deleted for the
triglyceride lipases TGL3 and TGL4 (tgl3Δ, tgl4Δ and tgl3Δ tgl4Δ) during
carbon starvation [11]. Several hypotheses could be postulated to
escape to the FFA toxicity. One would be the presence of sterol carrier
protein with fatty-acid and fatty-acyl-CoA binding activity [9,14],
(Fig. 12). Another one would be the transport of long-chain fatty acids
into the mitochondria in parallel to the YlPxa1p–YlPxa2p peroxisomal
transporter pathway. Indeed, carnitine was shown to be involved for
the transport of long-chain fatty acids into mitochondria in mammals
[28].
In order to validate our proposed model we reconstructed a meta-
bolic model using Raven toolbox [1] which was composed of 42
reactions and 15 metabolites localized in 4 different compartments
(extracellular, cytoplasm, peroxisome and lipid body). This mathemati-
cal framework allowed us to make predictions, by using ﬂux balance
analysis, in the biomass and lipid bodies' formation capacities of differ-
ent genetic backgrounds using different fatty acids as carbon sources.
We therefore compared the predicted values with our experimental
data (Table 3), which proved a high reliability of the proposed model,
showing only four minor mismatches. These differences were all
found in the ability to use C6:0 by mutants ΔYlant1, which point out
to an alternative pathway to degrade this fatty acids, that could beassociated to mitochondria such as suggested in [18]. Additionally, this
metabolic model can be included in the two previously published
genome scale metabolic model of Y. lipolytica [32,39], which are not
well deﬁned in their pathways to transport and activate fatty acids.
Hence, this will lead to the improvement of the accuracy of future pre-
dictions using any of the genome scale metabolic models.
Understanding how FAs can be activated in peroxisomes is of great
interest. Until now, no proteins demonstrating such a function had
been identiﬁed. However, the recent biochemical characterization of
enzymes encoded by peroxisomal 4-coumarate:coenzyme A ligase-
like genes shows that such proteins generally do not convert the
substrates accepted by true 4-coumarate CoA ligase enzymes to the cor-
responding CoA esters [8,25]. Indeed, many accept fatty acyl
substrates—such as 12-oxo-phytodienoic acid (OPDA) and OPDA deriv-
atives (jasmonic acid precursors; [25,27])—and medium- to long-chain
fatty acids [25,48]. For example, the product yielded by At4g05160 is
able to activate medium- and long-chain fatty acids, medium-chain
fatty acids bearing phenyl substitutions, and jasmonic acid precursors
(12-oxo-phytodienoic acid and 3-oxo-2-(2′-pentenyl)-cyclopentane-
1-hexanoic acid). In contrast, the product yielded by At5g63380 was
only able to activate medium- and long-chain fatty acids and 12-oxo-
phytodienoic acid [48]. We found that Y. lipolytica has 10 genes coding
for putative 4-coumarate-CoA ligases-like that are potentially found in
peroxisomes. These proteins could be equivalent in function to ScFaa2p
in S. cerevisiae, and further research is needed to clarify FA peroxisomal
activation in Y. lipolytica.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbalip.2015.04.004.
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Table 3
Comparison between mathematical model and experimental results.
Strain Carbon
source
Biomass Lipid bodies
Experimental Predicted Experimental Predicted
WT (JMY2900) C18:1 ● ● ● ●
C10:0 ● ●
C6:0 ● ●
ΔYlfaa1 C18:1 ● ● ○ ○
C10:0 ● ●
C6:0 ● ●
ΔYlant1 C18:1 ● ● ● ●
C10:0 ○ ○
C6:0 ○/w ○
ΔYlpxa1 C18:1 ● ● ● ●
C10:0 ● ●
C6:0 ● ●
ΔYlpxa2 C18:1 ● ● ● ●
C10:0 ● ●
C6:0 ● ●
ΔYlpxa1
ΔYlpxa2
C18:1 ● ● ● ●
C10:0 ● ●
C6:0 ● ●
ΔYlpxa1
ΔYlpxa2
ΔYlant1
C18:1 ○ ○ ● ●
C10:0 ○ ○
C6:0 ○/w ○
ΔYlpxa1
ΔYlant1
C18:1 ○ ○ ● ●
C10:0 ○ ○
C6:0 ○/w ○
ΔYlpxa2
ΔYlant1
C18:1 ○ ○ ● ●
C10:0 ○ ○
C6:0 ○/w ○
ΔYlfaa1
ΔYlant1
C18:1 ○ ○ ○ ○
C10:0 ○ ○
C6:0 ○ ○
ΔYlfat1 C18:1 ● ● ● ●
C10:0 ● ●
C6:0 ● ●
ΔYlpxa1
ΔYlpxa2
ΔYlfat1
C18:1 ● ● ● ●
C10:0 ● ●
C6:0 ● ●
ΔYlpxa1
ΔYlpxa2
ΔYlant1
ΔYlfat1
C18:1 ○ ○ ● ●
C10:0 ○ ○
C6:0 ○ ○
The table shows the validation of the proposedmodel for activation and transport of fatty
acids in Yarrowia lipolytica by comparing the predictions of the reconstructed mathemat-
ical model to the experimental results. Different backgrounds were tested for their capac-
ity to grow in fatty acids C18:1, C10:0 or C6:0both in vivo (Experimental data) and in silico
(Predicted). Additionally, their ability to produce lipid bodies from external C18:1 was
compared. ● growth/lipid bodies formation, ○ no growth/no lipid bodies formation, ○/
w very weak growth or residual growth.
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